Lapatinib Terminated Phase 2 Trials for Cancer, Breast / Cancer of the Breast / Neoplasms, Breast Treatment

TerminatedTreatment2 IdentifierTitleDrugs
NCT00657137APRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer (TP2001-202)
NCT01272141A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer
NCT00756470Phase II Neoadjuvant in Inflammatory Breast Cancer
NCT00754702Vinorelbine Metronomic Plus Lapatinib for Overexpressing HER-2 Metastatic Breast Cancer
NCT00499681PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORE
NCT00820924Study of Lapatinib in Breast Cancer Patients With HER-2 Non-amplified Primary Tumors and HER-2 Positive or EGFR Positive Circulating Tumor Cells
NCT00437073Brain Metastases In ErbB2-Positive Breast Cancer
NCT00709618Lapatinib + Vinorelbine in ErbB2 Overexpressing, First or Second Line Metastatic Breast Cancer Subjects